🔗 Share this article

Given that the US continues making historic adjustments to its vaccine guidelines, a particular individual has emerged somewhat surprisingly: Dr. Tracy Beth Høeg, a US-based sports physician and epidemiologist who first made her name by questioning Covid vaccines throughout the global health crisis and has zeroed in on potential fatalities following Covid vaccination in her recent time at the FDA.

Planned Shifts to Pediatric Immunization Program

Agency leaders planned to announce radical changes to the childhood immunization program earlier this month, bringing the US with Denmark’s vaccine program, sources say – a substantial departure that would place the US at odds with much of the world with little proof for benefit. This reveal has been delayed until the next year.

In place of the director of the vaccine center, Tracy Beth Høeg is scheduled to speak at the event. She was recently named temporary leader of the FDA’s drug evaluation center, the fifth appointee to lead the center this calendar year.

Consolidating Power at the Regulatory Body

Høeg's temporary position might represent a strengthened alliance between the pharmaceutical and vaccine branches as Dr. Høeg and Dr. Prasad solidify control at the FDA – and it points to a greater focus upon dismantling long-standing vaccines at the FDA.

The new acting director has repeatedly called for ending specific childhood immunization guidelines in the US in order to be more similar to the Danish model, a country with comprehensive healthcare and a citizenry about the population of the state of Wisconsin.

In her initial comments, she has kept her attention on immunizations – usually the purview of Prasad, head of the FDA’s CBER – as opposed to pharmaceutical oversight.

Doubts Over Background

Høeg has no obvious background in drug development, approval processes or leadership, which has been typical for past leaders of the Center for Biologics Evaluation and Research. She has served at the FDA as a top consultant to the commissioner and the vaccine center since March.

“She doesn’t seem to have the necessary background” for running the CDER, remarked Jonathan Howard. “She has not conducted a clinical trial. She lacks experience in leading a sizeable institution. She has no expertise in pharmaceutical oversight.”

Former commissioners of CBER would “understand laws and regulations and the science of medication creation”, commented Janet Woodcock. “Frankly, she lacks the sort of resume that previous people who headed the center have had.”

CDER has an enormous range of responsibilities at the FDA, she pointed out.

“The public just focuses on the innovative therapies, but the generic drug division clears numerous generic drugs. There’s a biologic copycat branch, OTC medication office and more, and every single one have to be managed,” Woodcock noted. “The thing you don’t keep your eye on, that is precisely what that I always told people is going to cause problems.”

Furthermore, a significant administrative aspect to the role, which manages in excess of 5,000 personnel. “It is a huge leadership role, if you perform it correctly,” she concluded.

Response and Disputed Programs

In response to questions about Dr. Høeg's credentials and whether this selection indicates more teamwork among agency officials on vaccines, a representative stated that the “inquiries stem from incorrect assumptions”.

“Her experience matches the responsibilities of her position,” the spokesperson stated, noting the time Dr. Høeg spent guiding the FDA commissioner on “pharmaceutical safety and oversight research, including computational safety modeling and immunization monitoring”.

In her interim role, Dr. Høeg takes over the commissioner’s controversial expedited review system, a disputed expedited therapy clearance system that allegedly concerned her preceding directors. “By what process are these medications being selected for this expedited pathway? Who takes the calls?” Howard said. “There is a lot of secrecy happening at the regulatory body right now.”

Overall, he remarked, “the Food and Drug Administration appears to be shifting towards more relaxed regulations of pharmaceuticals, with the exception of immunizations.”

Established History on Vaccines

Concerning vaccines, Dr. Høeg has a clearer, if concerning, history, critics said. She released a analysis using unverified crowd-sourced reports to assess the frequency of heart inflammation following Covid immunization. She counseled the Florida top health official Dr. Joseph Ladapo, who was said to have changed statistics to indicate Covid vaccines are more dangerous than they are.

Among her “wish list” for the new federal leadership encompassed revising guidelines for recently developed shots and discontinuing “optional” immunizations, she remarked following the vote on a audio program. At the agency, Høeg has allegedly suggested preventing young men from receiving COVID-19 vaccines.

“She’s an complete dogmatist who starts off with her preconceived notions and tailors the evidence to accommodate the science in a highly disingenuous, dishonest fashion,” Howard stated.

Taking Control and a “Campaign of Retribution”

Dr. Høeg became part of fellow contrarians, {like|